Literature DB >> 18348511

PepLine: a software pipeline for high-throughput direct mapping of tandem mass spectrometry data on genomic sequences.

Myriam Ferro1, Marianne Tardif, Erwan Reguer, Romain Cahuzac, Christophe Bruley, Thierry Vermat, Estelle Nugues, Marielle Vigouroux, Yves Vandenbrouck, Jérôme Garin, Alain Viari.   

Abstract

PepLine is a fully automated software which maps MS/MS fragmentation spectra of trypsic peptides to genomic DNA sequences. The approach is based on Peptide Sequence Tags (PSTs) obtained from partial interpretation of QTOF MS/MS spectra (first module). PSTs are then mapped on the six-frame translations of genomic sequences (second module) giving hits. Hits are then clustered to detect potential coding regions (third module). Our work aimed at optimizing the algorithms of each component to allow the whole pipeline to proceed in a fully automated manner using raw nucleic acid sequences (i.e., genomes that have not been "reduced" to a database of ORFs or putative exons sequences). The whole pipeline was tested on controlled MS/MS spectra sets from standard proteins and from Arabidopsis thaliana envelope chloroplast samples. Our results demonstrate that PepLine competed with protein database searching softwares and was fast enough to potentially tackle large data sets and/or high size genomes. We also illustrate the potential of this approach for the detection of the intron/exon structure of genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18348511     DOI: 10.1021/pr070415k

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  9 in total

1.  GAPP: A Proteogenomic Software for Genome Annotation and Global Profiling of Post-translational Modifications in Prokaryotes.

Authors:  Jia Zhang; Ming-Kun Yang; Honghui Zeng; Feng Ge
Journal:  Mol Cell Proteomics       Date:  2016-09-14       Impact factor: 5.911

Review 2.  Methods, Tools and Current Perspectives in Proteogenomics.

Authors:  Kelly V Ruggles; Karsten Krug; Xiaojing Wang; Karl R Clauser; Jing Wang; Samuel H Payne; David Fenyö; Bing Zhang; D R Mani
Journal:  Mol Cell Proteomics       Date:  2017-04-29       Impact factor: 5.911

3.  Proteogenomic analysis of Bradyrhizobium japonicum USDA110 using GenoSuite, an automated multi-algorithmic pipeline.

Authors:  Dhirendra Kumar; Amit Kumar Yadav; Puneet Kumar Kadimi; Shivashankar H Nagaraj; Sean M Grimmond; Debasis Dash
Journal:  Mol Cell Proteomics       Date:  2013-07-23       Impact factor: 5.911

4.  Ortho-proteogenomics: multiple proteomes investigation through orthology and a new MS-based protocol.

Authors:  Sébastien Gallien; Emmanuel Perrodou; Christine Carapito; Caroline Deshayes; Jean-Marc Reyrat; Alain Van Dorsselaer; Olivier Poch; Christine Schaeffer; Odile Lecompte
Journal:  Genome Res       Date:  2008-10-27       Impact factor: 9.043

Review 5.  Proteogenomics from a bioinformatics angle: A growing field.

Authors:  Gerben Menschaert; David Fenyö
Journal:  Mass Spectrom Rev       Date:  2015-12-15       Impact factor: 10.946

Review 6.  Proteogenomics: Integrating Next-Generation Sequencing and Mass Spectrometry to Characterize Human Proteomic Variation.

Authors:  Gloria M Sheynkman; Michael R Shortreed; Anthony J Cesnik; Lloyd M Smith
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2016-03-30       Impact factor: 10.745

7.  The proteogenomic mapping tool.

Authors:  William S Sanders; Nan Wang; Susan M Bridges; Brandon M Malone; Yoginder S Dandass; Fiona M McCarthy; Bindu Nanduri; Mark L Lawrence; Shane C Burgess
Journal:  BMC Bioinformatics       Date:  2011-04-22       Impact factor: 3.307

8.  PGx: Putting Peptides to BED.

Authors:  Manor Askenazi; Kelly V Ruggles; David Fenyö
Journal:  J Proteome Res       Date:  2015-12-18       Impact factor: 4.466

Review 9.  Proteomics progresses in microbial physiology and clinical antimicrobial therapy.

Authors:  B Chen; D Zhang; X Wang; W Ma; S Deng; P Zhang; H Zhu; N Xu; S Liang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-04       Impact factor: 3.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.